Facebook
Twitter
Telegram
Report an ErrorKintara Therapeutics Income Statement 2011-2024 | KTRA
Annual Income Statement Kintara Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
5.96 M | 117 K | - | - | - | - | - | - | - | - | - | - | - |
Shares |
1.62 M | 974 K | 25.9 M | - | - | - | - | - | - | - | - | - | - |
Historical Prices |
3.68 | 0.12 | 0.415 | 1.8 | 0.536 | 3.61 | 14.5 | 46.9 | 8.3 | 7 | 9.5 | - | - |
Net Income |
-14.6 M | -22.7 M | -38.3 M | 9.13 B | -8.05 M | -11.1 M | -8.08 M | -8.86 M | -4.8 M | - | -8.29 M | -18.9 K | -33.1 K |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | -18.9 K | -33.1 K |
Interest Expense |
- | - | 30 K | - | - | - | - | - | 2.09 K | -8.14 K | 8.02 K | 7.52 K | 21.9 K |
EBITDA |
60 K | 60 K | 30 K | - | -8.67 M | -11.2 M | -8.54 M | -3.55 M | -4.72 M | - | -6.29 M | -18.9 K | -33.1 K |
Operating Expenses |
14.8 M | 22.7 M | 38.2 M | 8.14 B | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
5.48 M | 7.51 M | 9.76 M | 4.51 B | 4.74 M | 4.04 M | 3.32 M | 2.85 M | 2.17 M | - | 3.95 M | - | 33.1 K |
All numbers in USD currency
Quarterly Income Statement Kintara Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
44.6 M | 4.34 M | 1.72 M | 1.68 M | 1.64 M | 1.46 M | 1.55 M | 983 K | 971 K | 34.3 M | 828 K | 29.3 M | 24.8 M | 17.1 M | 24.8 M | 17.1 M | 11.4 M | 7.54 M | 11.4 M | 7.54 M | 2.42 M | 2.3 M | 24.2 M | 23 M | 22.6 M | 15.3 M | 22.6 M | 15.3 M | 11.4 M | 11.3 M | 11.4 M | 11.3 M | 11 M | 10.6 M | 44 M | 42.5 M | 37.8 M | 36.5 M | 37.8 M | 36.5 M | 31.5 M | 31.4 M | 31 M | 24.3 M | 3.94 M | 13 M | 3.94 M | 3.94 M | 4.47 M | 5.95 M | 5.21 M | 5.95 M |
Net Income |
-2.01 M | -1.02 M | -2.96 M | -3.26 M | -3.45 M | -4.6 M | -8.05 M | -5.36 M | -5.89 M | -5.97 M | -11.9 M | -6.64 M | -5.41 M | -19.5 M | -5.41 M | -19.5 M | -1.74 M | -1.61 M | -1.74 M | -1.61 M | -1.81 M | -1.99 M | -1.81 M | -1.99 M | -3.16 M | -2.67 M | -3.16 M | -2.67 M | -1.32 M | -2.29 M | -3.61 M | -2.29 M | 2.65 M | -1.62 M | -4.27 M | -1.62 M | -620 K | -1.52 M | 1.08 M | 1.32 M | 866 K | -6.79 M | -6.81 M | -7.41 M | -3.25 K | -428 K | -65 K | -4.16 K | -10.9 K | -3.86 K | -10.9 K | -3.86 K |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.25 K | -4.16 K | -7.4 K | -61.8 K | -10.9 K | -3.86 K | -10.9 K | -3.86 K |
Interest Expense |
- | - | - | - | - | - | - | - | - | 23 K | - | 7 K | 8 K | 8 K | 16 K | 8 K | - | - | - | - | - | - | - | - | - | - | - | 84.2 K | - | 1.23 M | - | -280 K | - | 2.09 K | - | - | - | -2.09 K | -2.09 K | -2.09 K | -2.04 K | -2.03 K | 1.99 K | 1.96 K | - | 1.9 K | 1.88 K | 1.86 K | - | - | - | - |
EBITDA |
- | - | - | - | 15 K | 15 K | 30 K | 15 K | 15 K | 15 K | 30 K | - | - | 1 K | 2 K | 1 K | - | 3 K | 5.6 K | 2.8 K | - | 6.66 K | 10.7 K | 6.66 K | - | 5.6 K | 11.2 K | 5.6 K | - | 3.86 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.25 K | -4.16 K | -7.4 K | -61.8 K | -10.9 K | -3.86 K | -10.9 K | -3.86 K |
Operating Expenses |
2.08 M | 1.02 M | 2.96 M | 3.3 M | 3.5 M | 4.65 M | 8.14 M | 5.36 M | 5.9 M | 5.97 M | 11.9 M | 6.6 M | 5.38 M | 19.5 M | 5.38 M | 19.5 M | 1.77 M | 1.64 M | 1.77 M | 1.64 M | 1.82 M | 2.01 M | 1.82 M | 2.01 M | 3.15 M | 2.68 M | 3.15 M | 2.68 M | 1.69 M | 2.05 M | 1.69 M | 2.05 M | 1.68 M | 1.08 M | 1.68 M | -1.08 M | 1.27 M | -1.12 M | -1.27 M | -1.12 M | -1.2 M | -1.3 M | 2.24 M | 1.55 M | 3.25 K | 448 K | 7.4 K | 422 K | 10.9 K | - | 6.83 K | - |
General and Administrative Expenses |
1.49 M | 908 K | 1.1 M | 1.3 M | 1.44 M | 1.48 M | 2.92 M | 1.88 M | 1.99 M | 2.18 M | 4.17 M | 2.76 M | 2.79 M | 1.53 M | 2.79 M | 1.53 M | 1.05 M | 914 K | 1.05 M | 914 K | 875 K | 986 K | 875 K | 986 K | 1.01 M | 745 K | 1.01 M | 745 K | 571 K | 1.32 M | 571 K | 1.32 M | 891 K | 474 K | 891 K | -474 K | 656 K | -445 K | -656 K | -445 K | -636 K | -741 K | 1.65 M | 1.58 M | - | 219 K | 395 K | 4.16 K | - | 3.86 K | - | - |
All numbers in USD currency